Fact-checked by Grok 2 weeks ago

LFNG

LFNG (Lunatic Fringe O-fucosylpeptide 3-β-N-acetylglucosaminyltransferase) is a gene located on 7p22.3 that encodes a fucose-specific β-1,3-N-acetylglucosaminyltransferase enzyme, which modifies family receptors by adding to O-fucose-linked glycans, thereby modulating signaling activity critical for and developmental processes. This step enhances the receptor's response to Delta-like ligands while inhibiting activation by ligands, establishing boundaries in signaling to ensure precise patterning during embryogenesis. The LFNG gene consists of 8 exons and is a homolog of the Drosophila gene, reflecting conserved roles in segmentation and boundary formation across species. Expression of LFNG is dynamic and oscillatory in the presomitic (PSM), where it is regulated by a involving , Wnt, and FGF pathways, contributing to formation and vertebral segmentation. Beyond somitogenesis, LFNG is expressed in neural stem cells (NSCs) of the adult , where it promotes NSC self-renewal and by facilitating Notch-mediated feedback between progenitors and their progeny. It also plays roles in T-cell development in the and alveolarization, highlighting its broad influence on . Mutations in LFNG cause spondylocostal dysostosis 3 (SCDO3), an autosomal recessive disorder characterized by severe vertebral segmentation defects, multiple thoracic hemivertebrae, and rib anomalies. Additionally, LFNG variants have been implicated as candidate risk factors for autism spectrum disorder. Recent studies have further implicated LFNG in oncogenesis; elevated expression correlates with poor prognosis in cancers such as pancreatic adenocarcinoma, suggesting its involvement in tumor progression through dysregulated Notch signaling.

Gene and Protein

Genomic Location and Structure

The LFNG gene, encoding the lunatic fringe glycosyltransferase, was discovered in 1997 through cloning efforts aimed at identifying mammalian homologs of the fringe gene, which modulates signaling during developmental boundary formation, including somitogenesis. Researchers isolated three related genes—LFNG, MFNG (manic fringe), and RFNG (radical fringe)—demonstrating their sequence similarity to fringe and potential roles as pathway modifiers. This identification highlighted LFNG as a key paralog in the fringe , essential for . In humans, the LFNG gene is located on the short arm of at band p22.3, with genomic coordinates spanning 2,512,529 to 2,529,177 (GRCh38.p14 assembly), covering approximately 16.6 kb of genomic sequence. The comprises exons, with well-defined exon-intron boundaries that support the production of a primary protein-coding transcript, as well as multiple variants (e.g., isoforms with differing 5' UTRs or truncated coding regions). The orthologous Lfng in mice resides on (band G2) at coordinates 140,593,096 to 140,601,300 (GRCm39 assembly), spanning about 8.2 kb and consisting of 8 exons. LFNG exhibits strong evolutionary across vertebrates, with orthologs present in diverse species including chimpanzees, dogs, chickens, , and frogs, reflecting its role in Notch-mediated patterning. As one of the three mammalian fringe paralogs derived from ancient duplications, LFNG shares structural and functional homology with fringe, underscoring the preservation of this regulatory mechanism from to higher vertebrates.

Protein Structure and Domains

The LFNG protein, encoded by the LFNG gene on human , consists of 379 with a calculated molecular weight of approximately 41.8 . It is synthesized as a pre-pro-protein that undergoes processing to function as a type II transmembrane . The protein features an N-terminal hydrophobic region (amino acids 1-86) that acts as a type II transmembrane domain, serving as a signal anchor for insertion into the membrane during translation, without a cleavable . This domain orients the short cytoplasmic tail () toward the and positions the bulk of the protein in the of the secretory pathway. The central and C-terminal portion of LFNG (amino acids 87-379) forms the enzymatically active domain, a catalytic region characteristic of beta-1,3-N-acetylglucosaminyltransferases. This extends into the Golgi and contains key structural motifs essential for its , including the conserved DXD motif (aspartate-X-aspartate) at positions 200-202. The DXD motif coordinates metal ions, such as Mn²⁺, to facilitate nucleotide-sugar binding and catalysis in a manner typical of inverting glycosyltransferases. Structural studies indicate that the domain adopts a GT-B fold, common among glycosyltransferases, with flexible loops that enable substrate recognition and transfer. LFNG is primarily localized to the Golgi apparatus, where it anchors via its to perform its modifications on substrates transiting the secretory pathway. Immunofluorescence studies in mammalian cells expressing tagged LFNG variants confirm this perinuclear, Golgi-specific staining, colocalizing with markers such as GM130, and demonstrate that mutations disrupting the can lead to mislocalization and loss of function. Post-translational processing, including cleavage by proprotein convertases within the Golgi, further matures the protein by trimming N-terminal sequences to optimize its luminal activity.

Biochemical Function

Enzymatic Activity

LFNG, also known as lunatic fringe, functions as an O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, classified under EC 2.4.1.222, which catalyzes the addition of (GlcNAc) to O-fucose residues within (EGF)-like repeats of substrate proteins. This enzyme belongs to the GT31 family of glycosyltransferases and specifically elongates O-fucose modifications by forming a β1,3-glycosidic linkage, resulting in the GlcNAc-β1,3-O-Fuc. This GlcNAc can be further extended by β1,4-galactosyltransferase (e.g., B4GALT1) to form a branched tetrasaccharide on substrates. The reaction mechanism follows the inverting glycosyltransferase paradigm characteristic of GT-A fold enzymes, where LFNG transfers GlcNAc from the donor substrate uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) to the hydroxyl group of the terminal O-fucose on the acceptor substrate. This process requires coordination of a divalent metal cation, such as Mn²⁺, which is facilitated by the conserved DXD motif (Asp200-Asp201-Asp202 in human LFNG) in the active site; the motif helps position the UDP-sugar and enables a nucleophilic attack by the acceptor's hydroxyl oxygen on the anomeric carbon of GlcNAc, leading to inversion of configuration and release of UDP. In vitro assays confirm the dependence on Mn²⁺ (typically at 10 mM), with other cations like Mg²⁺ showing reduced efficiency. Kinetic studies using purified LFNG or its microbial homolog reveal low micromolar affinity for the donor substrate, with a Km value for UDP-GlcNAc of approximately 5.2 μM when assayed with para-nitrophenyl-α-L-fucose (pNP-fucose) as the acceptor. For acceptor substrates, Km values are higher, around 26.8 mM for pNP-fucose and an estimated 2 mM for O-fucosylated EGF peptides, reflecting the enzyme's adaptation to physiological concentrations of modified EGF domains. Optimal activity occurs at 6.5–7.5, as determined in buffer systems like at pH 6.8, with Vmax values reaching 132 nmol/min/mg for simple acceptors and kcat ≈ 2 s⁻¹ for EGF-based substrates in cell-free systems. LFNG exhibits strict substrate specificity, acting exclusively on O-fucosylated EGF-like domains and showing no activity toward other structures, such as O-linked glucose or unmodified serine/ residues. This selectivity is dictated by recognition of the residue and surrounding EGF fold elements, with minimal extension observed on non-fucosylated or alternative glycoforms. of the DXD motif abolishes this specificity, confirming its role in precise donor-acceptor positioning.

Role in Notch Signaling

Lunatic Fringe (LFNG) plays a pivotal role in modulating Notch signaling by post-translationally glycosylating Notch receptors. Specifically, LFNG acts as a β1,3-N-acetylglucosaminyltransferase that elongates O-fucose residues on specific epidermal growth factor-like (EGF) repeats, such as EGF12 and EGF27, of Notch1-4, adding an N-acetylglucosamine (GlcNAc). This modification occurs in the Golgi apparatus and is essential for fine-tuning ligand-receptor interactions within the Notch pathway. By altering the glycosylation state of the Notch extracellular domain, LFNG influences the receptor's conformation and accessibility to ligands, thereby regulating downstream signaling events such as proteolytic cleavage. The impact of LFNG on Notch activation is context-dependent, primarily affecting ligand binding affinity and selectivity. LFNG enhances signaling induced by Delta-like ligands (e.g., Delta1) while inhibiting that mediated by Jagged ligands (e.g., Jagged1) on 1, promoting trans-interactions at cell boundaries and suppressing cis-interactions in other contexts. This differential modulation arises because the O-fucose-GlcNAc extension sterically hinders Jagged binding but facilitates Delta-like engagement, leading to varied outcomes in Notch and transcriptional activation. For instance, LFNG-modified exhibits increased sensitivity to Delta1, resulting in enhanced ADAM10-mediated S2 cleavage and subsequent γ-secretase S3 processing to release the Notch intracellular domain (NICD). Experimental evidence from glycosylation assays demonstrates how LFNG's activity directly alters Notch cleavage dynamics. Using synthetic EGF repeat peptides containing O-fucose, LFNG efficiently transfers GlcNAc to consensus sites within EGF12 and other modifiable repeats, confirming its substrate specificity and enzymatic efficiency. Co-culture assays with LFNG-expressing cells further show that this modification reduces Jagged1-induced Notch1 cleavage while boosting Delta1-induced cleavage, as measured by NICD release and activation, without affecting ligand binding per se but influencing downstream . Additionally, LFNG contributes to oscillatory dynamics in Notch signaling through its cyclic expression pattern, which synchronizes with Hes/Her feedback loops to generate rhythmic activation pulses. This temporal regulation ensures precise control over signaling thresholds in responsive tissues.

Biological Roles

Involvement in Somitogenesis

LFNG plays a pivotal role in the segmentation clock that governs somitogenesis, the process by which the presomitic mesoderm (PSM) periodically segments into s to form the . Its expression oscillates in the posterior PSM with a periodicity matching somite formation—approximately 2 hours in mice—driving cyclic activation and repression of downstream genes like Hes7. This oscillation facilitates synchronized cellular behavior across the PSM, ensuring coordinated somite budding. The cyclic expression of LFNG establishes anterior-posterior polarity within each through a -Dll1 feedback loop, where LFNG glycosylates receptors to inhibit their activation by Dll1 ligands in anterior regions, thereby restricting Dll1 expression to posterior halves. This modulation promotes differential cell fates: anterior cells contribute to the sclerotome and dermatome, while posterior cells form the . Without proper LFNG oscillation, lose polarity, leading to fused or irregular segments. LFNG expression responds to opposing morphogen gradients—high anteriorly and high FGF-8 posteriorly—to position boundaries at the wavefront-clock interface, where the clock phase aligns with low FGF-8 levels for stabilization. This ensures form at regular intervals along the embryonic . Somites differentiated under LFNG influence give rise to the (vertebrae and ribs), , and of the ; disruptions in LFNG activity result in malformed that yield defective vertebral fusions and rib anomalies, underscoring its necessity for . Lfng-null mice exhibit disorganized from embryonic day 9.5 onward, with hemivertebrae and missing ribs in 100% of mutants. Evidence from model organisms highlights LFNG's conserved function. In chick embryos, electroporation-induced overexpression or inhibition of Lfng disrupts oscillatory gene expression and causes irregular somite boundaries and polarity defects.

Expression Patterns and Regulation

LFNG exhibits dynamic spatial and temporal expression patterns during mouse embryogenesis, primarily in tissues undergoing segmentation and patterning. It is highly expressed in the presomitic mesoderm (PSM), developing somites, neural tube, and limb buds, where it contributes to oscillatory signaling prerequisites for boundary formation. In the PSM and nascent somites, expression manifests as dynamic waves, while in the neural tube and hindbrain, it appears more uniformly during early stages; limb bud expression is confined to the distal ectoderm. Temporally, LFNG expression initiates during around embryonic day (E) 7.5–8.5 in mice and peaks through somitogenesis until approximately E12.5–13.5, coinciding with the formation of the . In the PSM, transcripts oscillate cyclically every 2 hours, driven by the segmentation clock, with posterior-to-anterior traveling waves preceding boundary formation. In adult tissues, LFNG levels are markedly lower but detectable in the , particularly in quiescent neural stem cells of the hippocampal subgranular zone, and in reproductive structures including the , , and ovarian granulosa cells. Transcriptional regulation of LFNG involves a modular promoter and enhancer system responsive to upstream signaling pathways. The core promoter integrates inputs from Wnt and FGF signaling, which establish the posterior identity of the PSM and initiate clock oscillations; Wnt3a, for instance, is essential for maintaining cyclic LFNG expression by regulating Delta-like ligands. Distinct enhancers mediate tissue-specific and cyclic patterns: a posterior PSM enhancer drives ~2-hour oscillations via Notch-Dll1 feedback, while separate elements control expression in the rostral , , and . Post-transcriptional control fine-tunes LFNG levels to sustain oscillatory dynamics. MicroRNAs, notably miR-125a-5p, bind conserved sites in the LFNG 3' (UTR), promoting mRNA decay and preventing overexpression that could disrupt the segmentation clock; inhibition of miR-125a-5p in and PSM abolishes LFNG cyclicity and impairs formation. This regulation ensures precise temporal modulation during presomitic maturation.

Roles Beyond Somitogenesis

Beyond its essential function in somitogenesis, LFNG contributes to various developmental and adult tissue processes through Notch signaling modulation. In the adult , LFNG is expressed in neural stem cells (NSCs) of the subgranular zone, where it promotes NSC self-renewal and by facilitating -mediated feedback loops between progenitors and progeny. LFNG also plays a role in T-cell development within the , where it prolongs Delta- signaling-induced self-renewal of early T-cell progenitors, supporting efficient T-cell maturation. Additionally, LFNG is involved in lung alveolarization, contributing to proper branching and alveolar septation during postnatal .

Pathophysiology

Associated Disorders

The primary disorder associated with LFNG dysfunction is spondylocostal dysostosis 3 (SCDO3), an autosomal recessive condition characterized by severe vertebral anomalies from the to sacral regions, including multiple fusions and a distinctive "pebble-beach" appearance on , along with malformations such as fusions and deletions, resulting in a shortened , nonprogressive , and . Affected individuals often exhibit (typically -2.5 standard deviations below the mean) and may develop respiratory complications due to reduced thoracic volume, though the and long bones are generally unaffected. Hand anomalies, such as or slender fingers, have been reported in isolated cases. SCDO3 is extremely rare, with only a small number of cases (over 10 unrelated families) documented worldwide as of 2024, often in consanguineous families due to its autosomal recessive inheritance pattern. typically involves radiographic , such as X-rays or MRI, to identify the characteristic vertebral and rib defects, confirmed by for biallelic LFNG mutations, including missense variants like p.Phe188Leu or frameshifts. Beyond SCDO3, LFNG variants have been identified in some cases of congenital , presenting with vertebral malformations like hemivertebrae or block vertebrae, though these links are primarily observed within the spectrum of spondylocostal dysostoses rather than isolated . Mouse models of Lfng deficiency reveal due to defects in and meiotic maturation, but this has not been confirmed in humans. Additionally, loss of LFNG expression has an emerging role in promoting , with genomic alterations disrupting the gene observed exclusively in metastatic cases from large-scale sequencing efforts. Clinical management of SCDO3 is supportive and multidisciplinary, focusing on respiratory support through and monitoring for infections, orthopedic interventions like bracing or for progressive , and addressing complications such as hernias, with no curative treatment available.

Molecular Impacts of Mutations

Mutations in the LFNG gene, which encodes a β-1,3-N-acetylglucosaminyltransferase involved in O-linked fucosylation, predominantly consist of biallelic variants including missense substitutions in the catalytic Fringe domain, nonsense mutations, and splice-site alterations that disrupt enzyme function. For instance, the homozygous missense variant c.564C>A (p.F188L) in exon 3 mislocalizes the protein from the Golgi apparatus and abolishes GlcNAc-transferase activity, while compound heterozygous missense variants like c.766G>A (p.G256S) and c.521G>A (p.R174H) in the catalytic domain result in nonfunctional or hypomorphic enzymes with near-complete (up to 100%) or partial reductions in activity, respectively. Nonsense mutations, such as c.863dup (p.Asp289Ter), introduce premature stop codons leading to truncated proteins, and splice-site variants like the intronic c.822-5C>T disrupt normal splicing, significantly reducing LFNG mRNA expression in patient-derived cells. More recent studies (as of 2024) have identified additional biallelic variants, further delineating the genotype-phenotype spectrum in SCDO3. These variants impair the core enzymatic function of LFNG by preventing the addition of to O-fucose on (EGF)-like repeats of receptors, thereby disrupting O-fucosylation and subsequent modulation of Notch signaling. The loss of this modification abolishes LFNG's ability to potentiate Delta-like ligand (Dll1)- interactions while failing to inhibit Jagged1- signaling, resulting in dysregulated oscillatory expression of segmentation clock genes in the presomitic . Consequently, boundary formation is defective, leading to irregular segmentation, disorganized anterior-posterior polarity, and abnormal vertebral development characterized by hemivertebrae and fused segments. In models, Lfng recapitulates these molecular disruptions, exhibiting severe somitogenesis defects with irregular formation, truncated tails due to impaired axial , fused and malformed vertebrae, and anomalies arising from failed -mediated patterning. Additionally, homozygous Lfng-null females display stemming from meiotic pairing errors during oocyte maturation, highlighting broader impacts on reproductive tissues beyond skeletal development. These phenotypes underscore the essential role of LFNG in maintaining oscillatory signaling for proper clock function. Genotype-phenotype correlations in humans reveal that biallelic loss-of-function variants, whether homozygous missense like p.F188L or compound heterozygous combinations including nonsense and splice-site changes, consistently cause severe spondylocostal dysostosis type 3 (SCDO3) with profound vertebral segmentation defects and . In contrast, hypomorphic variants such as p.R174H may correlate with somewhat milder manifestations, including preserved stature and fewer vertebral anomalies (>20 vertebrae observed), though severity remains significant; heterozygous carriers typically show no clinical effects due to the autosomal recessive inheritance.

References

  1. [1]
    Entry - *602576 - LFNG O-FUCOSYLPEPTIDE 3-BETA-N ... - OMIM
    LFNG encodes a fucose-specific beta-1,3-N-acetylglucosaminyltransferase that modifies Notch receptors and alters Notch signaling activity.Missing: What | Show results with:What
  2. [2]
    Mutation of the LUNATIC FRINGE Gene in Humans Causes ...
    LFNG encodes a glycosyltransferase that modifies the Notch family of cell-surface receptors, a key step in the regulation of this signaling pathway. A missense ...
  3. [3]
    The lunatic Fringe gene is a target of the molecular clock linked to ...
    Here, we show that lunatic Fringe (lFng), a vertebrate homolog of the Drosophila Fringe gene, is also expressed rhythmically in PSM. The PSM expression of lFng ...Missing: What | Show results with:What
  4. [4]
    Lunatic fringe-mediated Notch signaling regulates adult ... - eLife
    Jul 12, 2017 · Here, we report that Lunatic fringe (Lfng), a key modifier of the Notch receptor, is selectively expressed in NSCs. Further, Lfng in NSCs and ...<|control11|><|separator|>
  5. [5]
    Lunatic Fringe prolongs Delta/Notch-induced self-renewal of ...
    Lunatic Fringe (Lfng) enhances Notch1 activation by Delta-like 4 (DL4) to promote Notch1-dependent T-lineage commitment of thymus-seeding progenitors.
  6. [6]
    Lunatic Fringe-mediated Notch signaling is required for lung ...
    Lunatic Fringe (Lfng) is a β1–3 N-acetylglucosamine transferase that modifies Notch receptors to facilitate their activation by Delta-like (Dll1/4) ligands.<|control11|><|separator|>
  7. [7]
    A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG ...
    Nov 6, 2023 · However, a comprehensive analysis of the Fringe family members lunatic fringe (LFNG), manic fringe (MFNG), radical fringe (RFNG) in human ...Missing: What | Show results with:What
  8. [8]
    3955 - Gene ResultLFNG LFNG O-fucosylpeptide 3-beta-N ... - NCBI
    Sep 27, 2025 · This gene is a member of the glycosyltransferase 31 gene family. Members of this gene family, which also includes the MFNG (GeneID: 4242) ...Missing: chromosome | Show results with:chromosome
  9. [9]
    16848 - Gene ResultLfng LFNG O-fucosylpeptide 3-beta-N ... - NCBI
    Sep 24, 2025 · Lunatic fringe (Lfng) expression in the presomitic mesoderm is required for somite segmentation. Independent Lfng regulatory cassettes advance a ...
  10. [10]
  11. [11]
    q8nes3 · lfng_human - UniProt
    Glycosyltransferase that initiates the elongation of O-linked fucose residues attached to EGF-like repeats in the extracellular domain of Notch molecules.
  12. [12]
    LFNG Gene - GeneCards | LFNG Protein | LFNG Antibody
    LFNG (LFNG O-Fucosylpeptide 3-Beta-N-Acetylglucosaminyltransferase) is a Protein Coding gene. Diseases associated with LFNG include Spondylocostal Dysostosis 3.Missing: What | Show results with:What
  13. [13]
    Integrative analysis of Lunatic Fringe variants associated with ...
    Jun 25, 2024 · Lunatic Fringe (LFNG) is required for spinal development. Biallelic pathogenic variants cause spondylocostal dysostosis type-III (SCD3), a rare disease.
  14. [14]
    (PDF) Integrative analysis of Lunatic Fringe variants associated with ...
    Jun 25, 2024 · PDF | Lunatic Fringe (LFNG) is required for spinal development. Biallelic pathogenic variants cause spondylocostal dysostosis type‐III ...
  15. [15]
    Structure and dynamic studies of lunatic, manic and radical fringe
    ... protein dynamics throughout the production run of 5 ns each for Lfng, Mfng and Rfng. The DxD (aspartate any residue aspartate) motif, a hallmark active site ...Missing: subcellular | Show results with:subcellular
  16. [16]
    Lunatic fringe protein processing by proprotein convertases may ...
    We localize N-terminal protein sequences that control the secretory behavior of fringe proteins and find that LFNG processing is promoted by specific proprotein ...Missing: subcellular | Show results with:subcellular
  17. [17]
  18. [18]
    Fringe-mediated extension of O-linked fucose in the ligand-binding ...
    The Notch receptor is regulated by O-glycosylation, a sugar modification that involves a series of enzyme-catalyzed additions to residues within EGF domains.
  19. [19]
    Fringe Glycosyltransferases Differentially Modulate Notch1 ...
    Here, we report that expression of mammalian fringe proteins (Lunatic [LFng], Manic [MFng], or Radical [RFng] Fringe) increased Delta1 binding and activation of ...
  20. [20]
    Fringe differentially modulates Jagged1 and Delta1 signalling ...
    Jul 18, 2000 · Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2. Carol Hicks,; Stuart H. Johnston,; Guy ...
  21. [21]
    Dynamic expression of lunatic fringe suggests a link between notch ...
    Mar 1, 1999 · Dynamic expression of lunatic fringe suggests a link between notch signaling and an autonomous cellular oscillator driving somite segmentation.
  22. [22]
    Lfng regulates the synchronized oscillation of the mouse ... - Nature
    Oct 16, 2012 · We provide a new model in which Lfng has a crucial role in intercellular coupling of the segmentation clock through a trans-repression mechanism.Results · Notch Signalling... · Lfng Represses Notch...Missing: discovery | Show results with:discovery
  23. [23]
    Transcriptional oscillation of Lunatic fringe is essential for ...
    If cyclic Lfng expression were central to the segmentation clock, noncyclic Lfng expression should disrupt oscillating gene expression. To address whether ...
  24. [24]
    The long and short of it: Somite formation in mice - Gridley - 2006
    May 24, 2006 · The function of the FGF8 gradient in determining the spacing of somatic boundaries is refined by a gradient of retinoic acid signaling activity ...
  25. [25]
    FGF4 and FGF8 comprise the wavefront activity that controls ... - PNAS
    This study provides genetic evidence that FGFs are the wavefront signal and identifies the specific FGF ligands that encode this activity.
  26. [26]
    Defects in somite formation in lunatic fringe-deficient mice - PubMed
    Here we show that mice homozygous for a targeted mutation of the lunatic fringe (Lfng) gene, one of the mouse homologues of fringe, have defects in somite ...Missing: knockout | Show results with:knockout
  27. [27]
    Sequence and embryonic expression of three zebrafish fringe genes ...
    Sep 16, 2004 · In this study, we describe the cloning and expression pattern of three zebrafish fringe homologues: lunatic fringe (lfng), radical fringe (rfng) ...
  28. [28]
    Transcriptional oscillation of Lunatic fringe is essential for ...
    These findings suggest that constitutive expression of Lfng that moderately elevates the level of endogenous Lfng is sufficient to disrupt normal somitogenesis, ...
  29. [29]
    Expression of Radical fringe in limb-bud ectoderm regulates apical ...
    The apical ectodermal ridge of the vertebrate limb bud lies at the junction of the dorsal and ventral ectoderm and directs patterning of the growing limb.
  30. [30]
    Imaging the onset of oscillatory signaling dynamics during mouse ...
    Jul 1, 2022 · To examine their onset during mouse embryo development, we studied the dynamics of the segmentation clock gene Lfng during gastrulation. To this ...Missing: temporal E8. 5 E12.
  31. [31]
    Differential Axial Requirements for Lunatic Fringe and Hes7 ...
    The dispensability of Lfng for the formation of sacral somites and vertebrae might be due to changing requirements for Notch signalling during axial elongation.<|control11|><|separator|>
  32. [32]
    Lunatic fringe-mediated Notch signaling regulates adult ...
    We propose a new model in which Lfng-mediated Notch signaling enables direct communication between a NSC and its descendants, so that progeny can send feedback ...
  33. [33]
    A deficiency of lunatic fringe is associated with cystic dilation of the ...
    Therefore, Lfng is expressed in the developing efferent ducts, epididymis, and rete testis. This was compared with the expression pattern of Notch2 and Notch3 ...
  34. [34]
    Notch signaling represses GATA4-induced expression of genes ...
    In mice deficient for Lunatic fringe (Lfng), a modifier of the extracellular domain of the Notch receptors, Notch signaling was inhibited in granulosa cells and ...
  35. [35]
    mir-125a-5p-Mediated Regulation of Lfng Is Essential for the Avian ...
    Mar 11, 2013 · Here, we demonstrate that microRNA-mediated regulation of Lfng is essential for proper segmentation during chick somitogenesis.
  36. [36]
    Putative binding sites for mir-125 family miRNAs in the mouse Lfng 3 ...
    In the mouse and chicken clock, Lfng acts in a negative feedback loop that requires transcriptional activation by Notch and repression by the bHLH repressor ...
  37. [37]
    Species-specific roles of the Notch ligands, receptors, and targets ...
    Posterior skeletal development and the segmentation clock period are sensitive to Lfng dosage during somitogenesis. Dev. Biol. 388, 159–169. doi:10.1016/J ...<|separator|>
  38. [38]
    609813 - SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL ...
    Autosomal recessive spondylocostal dysostosis-3 (SCDO3) is caused by homozygous or compound heterozygous mutation in the LFNG gene (602576) on chromosome 7p22.
  39. [39]
    Autosomal recessive spondylocostal dysostosis - Orphanet
    The precise incidence and prevalence are unknown. Cases have been described worldwide. The carrier frequency may be around 1 in 350 in non-consanguineous ...Missing: SCDO3 | Show results with:SCDO3
  40. [40]
  41. [41]
    Screening of known disease genes in congenital scoliosis - PMC
    The CS patient with LFNG mutations had multiple vertebral malformations including hemivertebrae, butterfly vertebrae, and block vertebrae, and rib malformations ...
  42. [42]
    Lunatic fringe null female mice are infertile due to defects in meiotic ...
    Lunatic fringe null female mice were found to be infertile. Histological analysis of the lunatic fringe-deficient ovary demonstrated aberrant folliculogenesis.
  43. [43]
    Comparative genomics reveals that loss of lunatic fringe (LFNG ...
    Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis ... tumor suppressor gene expression in cutaneous melanoma. Clin ...
  44. [44]
    Spondylocostal Dysostosis, Autosomal Recessive - GeneReviews
    Aug 25, 2009 · Prevalence. DLL3-related SCDO. Seventy-five percent of individuals ... SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3. 609891 ...
  45. [45]
    Functional Characterization of Novel Lunatic Fringe Variants in ...
    Pathogenic variants in the LUNATIC FRINGE (LFNG) gene can cause spondylocostal dysostosis type-III (SCD3), which is a rare skeletal dysplasia characterized by ...
  46. [46]
    Identification of bi‐allelic LFNG variants in three patients and further ...
    Apr 10, 2023 · Molecular defects in these genes are found in 20%–25% of SCD individuals, with DLL3 representing the major causative gene. Unfortunately, most ...
  47. [47]
    Lunatic fringe null female mice are infertile due to defects in meiotic ...
    Feb 15, 2005 · The Notch gene family encodes transmembrane receptors that are highly conserved evolutionarily ... Fringe, the homolog of Lfng, is ...Results · Notch Family Gene Expression... · Introduction<|control11|><|separator|>